Article

Pricing Treatments Cost-Effectively When They Have Multiple Indications: Not Just a Simple Threshold Analysis

2023-02-08

Abstract excerpt

<h4>Background</h4> Economic evaluations of treatments increasingly employ price-threshold analyses. When a treatment has multiple indications, standard price-threshold analyses can be overly simplistic. We examine how rules governing indication-specific prices and reimbursement decisions impact value-based price analyses. <h4>Methods</h4> We analyze a two-stage game between two players: the therapy’s manufacturer...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7a34aa2d-443c-56de-aad1-63c2e248749e
DOI: 10.1101/2023.02.07.23285597

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pricing Treatments Cost-Effectively When They Have Multiple Indications: Not Just a Simple Threshold AnalysisDOI 10.1101/2023.02.07.23285597Read

Methodological Challenges in Dutch HTA of Non-Oncological Orphan Drugs: A Retrospective Analysis and Price Comparison Using different Pricing ModelsSemantic proximity Read

Applying the Efficiency Frontier to Inform Value-Based Pricing for Gaucher Disease Therapies in BrazilSemantic proximity Read

Treatment recommendations based on Network Meta-Analysis: rules for risk-averse decision-makersSemantic proximity Read

Guiding the willingness to pay for repurposed tiratricol in the treatment of Allan-Herndon-Dudley syndrome using a cost-based-plus pricing frameworkSemantic proximity Read

A Game-Theoretic Perspective on Disease-Modifying Therapy Choice in Resource-Limited SettingsSemantic proximity Read

The Impact of the Inflation Reduction Act on Investment in Innovative Medicines: A Project- Level AnalysisSemantic proximity Read

Proposal for a Value-Based Agreement to Reimburse Anti-obesity Medicines in Traditional MedicareSemantic proximity Read

Availability, Prices and Affordability of Nationally Negotiated Antidiabetic Drugs in China: A National SurveySemantic proximity Read

Patient Perspective—Where Does the Value for Money of a Treatment Really Lie?Semantic proximity Read

Comparison Between Sotorasib with Docetaxel for the Treatment of Chinese Patients with Previously Treated NSCLC with KRASG12C Mutation: A Cost-Effectiveness Analysis to Inform Drug Pricing.Semantic proximity Read

Cost of Goods Sold Analysis for Manufacturing mRNA-Based Cell and Gene TherapiesSemantic proximity Read

Estimated Costs of Production Compared with National Prices, for Drugs to Treat Clinical ObesitySemantic proximity Read